Axsome Therapeutics, Inc. financial data

Symbol
AXSM on Nasdaq
Location
One World Trade Center, 29 Th Floor, New York, NY
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 3, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 177 % -38.2%
Quick Ratio 6.31 % -30.2%
Debt-to-equity 863 % +167%
Return On Equity -357 % -52.4%
Return On Assets -37.1 % +33.1%
Operating Margin -37.9 % +58.2%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 50.4M shares +4.02%
Common Stock, Shares, Outstanding 50.3M shares +3.86%
Entity Public Float 3.2B USD +14.3%
Common Stock, Value, Issued 5K USD 0%
Weighted Average Number of Shares Outstanding, Basic 50M shares +3.91%
Weighted Average Number of Shares Outstanding, Diluted 50M shares +3.91%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 561M USD +65.8%
Research and Development Expense 189M USD +16.3%
Selling and Marketing Expense 385M USD +67.5%
General and Administrative Expense 62.4M USD +70.4%
Costs and Expenses 774M USD +20%
Operating Income (Loss) -212M USD +30.6%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -230M USD +26%
Income Tax Expense (Benefit) -875K USD -169%
Net Income (Loss) Attributable to Parent -230M USD +26.2%
Earnings Per Share, Basic -4 USD/shares +29.2%
Earnings Per Share, Diluted -4 USD/shares +29.2%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 325M USD -0.63%
Accounts Receivable, after Allowance for Credit Loss, Current 197M USD +58.4%
Inventory, Net 23.8M USD +66.7%
Assets, Current 565M USD +18%
Property, Plant and Equipment, Net 605K USD -11.4%
Operating Lease, Right-of-Use Asset 21.7M USD +278%
Intangible Assets, Net (Excluding Goodwill) 42.1M USD -13.1%
Goodwill 12M USD 0%
Assets 669M USD +19.2%
Accounts Payable, Current 54.2M USD -15.6%
Employee-related Liabilities, Current 27.8M USD +43.5%
Liabilities, Current 360M USD +83.6%
Operating Lease, Liability, Noncurrent 23M USD +258%
Liabilities 596M USD +27.1%
Retained Earnings (Accumulated Deficit) -1.28B USD -21.9%
Stockholders' Equity Attributable to Parent 73.7M USD -20.6%
Liabilities and Equity 669M USD +19.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -43.4M USD +18.9%
Net Cash Provided by (Used in) Financing Activities 29.3M USD
Net Cash Provided by (Used in) Investing Activities -338K USD -245%
Common Stock, Shares Authorized 150M shares 0%
Common Stock, Shares, Issued 50.3M shares +3.86%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -14.4M USD +73.6%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 325M USD -0.63%
Interest Paid, Excluding Capitalized Interest, Operating Activities 4.59M USD -6.38%
Deferred Tax Assets, Valuation Allowance 282M USD +26.3%
Deferred Tax Assets, Gross 285M USD +26.4%
Operating Lease, Liability 23.8M USD +195%
Depreciation 149K USD +12.9%
Payments to Acquire Property, Plant, and Equipment 338K USD +245%
Lessee, Operating Lease, Liability, to be Paid 29.9M USD +185%
Operating Lease, Liability, Current 736K USD -54.8%
Lessee, Operating Lease, Liability, to be Paid, Year Two 4.79M USD +90%
Lessee, Operating Lease, Liability, to be Paid, Year One 2.18M USD +10.2%
Operating Lease, Weighted Average Discount Rate, Percent 0.12 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 6.08M USD +153%
Lessee, Operating Lease, Liability, to be Paid, Year Three 4.81M USD +90.7%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 11.3M USD +252%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 6.38M USD -0.27%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Share-based Payment Arrangement, Expense 93M USD +15.4%
Interest Expense -18.1M USD +40.4%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%